According to the news from the Wisdom Financial APP, Wai Yuen Tong (00897) surged more than 52%. As of publication, it rose 52.26%, reaching HKD 0.37, with a turnover of HKD 2.1572 million.

On the news front, Wai Yuen Tong announced its annual results until March 31, 2024. The group received revenue of HKD 784 million, an increase of 8.3% year-on-year; the loss attributable to shareholders of the parent company was HKD 15.356 million, a decrease of 25.15% year-on-year; it plans to distribute a final dividend of HKD 0.03 per share and a special dividend of HKD 0.147 per share.

The company pointed out that the decrease in losses was mainly due to the increase in gross profit generated by the production and sales of pharmaceuticals and health products, income from the sale of property, factory buildings, and equipment projects, the increase in fair value losses of self-owned investment properties, the increase in losses from the sale/redemption of debt investment, and the increase in impairment losses of property, factory buildings, and equipment projects.